SYRS Syros Pharmaceuticals
- 0.2000
- -0.0018-0.89%
Syros Pharmaceuticals News
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Simonian Nancy A
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Simonian Nancy A
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Haas Jason
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Chee Conley
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Quirk Gerald E
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Roth David
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Stephens Kristin
Syros Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avidity Partners Management LP(9.9%),Avidity Partners Management (GP) LLC(9.9%), etc.
Syros Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bain Capital Life Sciences Fund II, L.P.(9.99%)
Syros Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Blue Owl Capital Holdings LP(1.92%)
Syros Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(9.9%),Invus Public Equities Advisors, LLC(9.9%), etc.
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Stephens Kristin
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Chee Conley
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Haas Jason
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Roth David
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Simonian Nancy A
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Quirk Gerald E
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director AKKARAJU SRINIVAS
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Young Richard A
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Chee Conley
No Data